133750 — MegaMD Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro CapContrarian

Annual income statement for MegaMD Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	82,440	79,435	64,468	36,041	36,491
Cost of Revenue
Gross Profit	50,814	48,891	39,002	20,034	21,855
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	76,186	74,620	62,660	41,218	34,310
Operating Profit	6,253	4,815	1,808	-5,177	2,182
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	7,268	7,935	2,641	-3,177	4,810
Provision for Income Taxes
Net Income After Taxes	4,885	6,650	2,113	-3,197	3,783
Minority Interest
Net Income Before Extraordinary Items
Net Income	4,897	6,650	2,113	-3,197	3,783
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4,897	6,650	2,113	-3,197	3,783
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	256	411	118	-95.2	175
Dividends per Share